PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
02-May-2025 Global Prosthetics and Orthotics Market to Surpass USD 13,300.5 Million by 2035, Driven by Technological Innovation and Rising Healthcare Demand | FMI MARKITWIRED
02-May-2025 Hemogenyx Pharmaceuticals PLC Announces Second Patient Treated with HG-CT-1 CAR-T Therapy ACCESS Newswire
02-May-2025 Global Triple X Syndrome Management Market Expected to Surpass USD 268.63 Million by 2033 register a CAGR of 6% | FMI Report MARKITWIRED
02-May-2025 Tuberculous Meningitis Treatment Market Forecasted to Reach USD 339,092.8 Million by 2035 Amid Advancements in CNS-Targeted Therapeutics | FMI MARKITWIRED
02-May-2025 Global Large Granular Lymphocytic Leukemia (LGLL) Therapeutics Market to Reach USD 17,051.4 Million by 2035, Driven by Targeted Therapy Innovation and Enhanced Diagnostics | FMI MARKITWIRED
02-May-2025 Vaginal and Vulval Inflammatory Diseases Treatment Market to Surpass USD 5,500.7 Million by 2035 Amid Rising Awareness and Technological Innovation | FMI MARKITWIRED
02-May-2025 Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Treatment Market to Surpass USD 9,578.28 Million by 2035: Driven by Targeted Therapies, Clinical Trials, and Technological Innovation | FMI MARKITWIRED
02-May-2025 Global Idiopathic Pulmonary Fibrosis Management Market to Reach USD 3,850.1 Million by 2035 Amidst Steady Advances in Therapy and Diagnosis | FMI MARKITWIRED
02-May-2025 Global Transfusion Dependent Thalassaemia Management Market to Reach USD 21.5 Million by 2035, Driven by Breakthroughs in Gene Therapy and Iron Chelation Treatments | FMI MARKITWIRED
02-May-2025 Global Ringworm Treatment Market Set to Surpass USD 15,106.66 Million by 2035 Amid Rising Fungal Infections and OTC Drug Accessibility | FMI MARKITWIRED
02-May-2025 Vicore to Present at the Nordea Equities Healthcare Seminar ACCESS Newswire
01-May-2025 BioNxt Solutions Announces Delay In Filing 2024 Annual Financial Statements ACCESS Newswire
01-May-2025 Venture Medical Announces Strategic Partnership With Plasmacure to Bring Proven Cold Plasma Therapy System for Wound Healing to the U.S. Market ACCESS Newswire
01-May-2025 The Silent Trailblazer: Dr. Azriel Hirschfeld, Oncology's Best-Kept Secret ACCESS Newswire
01-May-2025 PharmaNest Launches FibroMAP, the First Single-Fiber Phenotypic Tool for the Study of Fibrosis Across Biological Models and Indications Newswire
01-May-2025 Camgenium and Cardiac Tech Partner to Improve Patient Outcomes Post-Cardiac Surgery with Pace-Protect System Camgenium
01-May-2025 Alzheimer’s Family of Friends Foundation Offers Urgent Financial Relief for Families Affected by Dementia ACCESS Newswire
01-May-2025 UK Company, Stablepharma Ltd, enters Phase 1 Clinical Trials with world-first Fridge-Free Tetanus & Diphtheria Vaccine Stablepharma Ltd
01-May-2025 First patient enrolled in Phase 1 clinical trial of Akiram’s cancer drug candidate AKIR001 Akiram Therapeutics
01-May-2025 PureTech to Present Results from Phase 2b ELEVATE IPF Trial of Deupirfenidone (LYT-100) at the American Thoracic Society International Conference PureTech